E-viri
Recenzirano
-
Espay, Alberto J
Lancet neurology, 20/May , Letnik: 21, Številka: 5Journal Article
While this medication is only meant to alleviate your symptoms, not treat your disease, the pharmacogenomic analysis indicated that you can expect to achieve optimal benefits, with a small risk of developing low blood pressure at doses higher than 750 mg/day. ...we will continue optimising the control of your symptoms only with carbidopa and levodopa. For treating your specific type of disease Our continuously updated biorepository searches for the 16 recognised biological types of Parkinson's disease that account for approximately 25% of known presentations. Because treatments are available to correct the biological abnormalities underpinning each of these disease types, our centre automatically applies a battery of treatment-linked bioassays to identify candidates likely to benefit from them.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.